Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reductionist Three-Dimensional Tumor Microenvironment Models in Synthetic Hydrogels. | Cancers (Basel) | 2022 | 35267532 | PubTator, text mining | PubMed |
| Can Heart Valve Decellularization Be Standardized? A Review of the Parameters Used for the Quality Control of Decellularization Processes. | Front Bioeng Biotechnol | 2022 | 35252139 | PubTator, text mining | PubMed |
| The Induced Expression of BPV E4 Gene in Equine Adult Dermal Fibroblast Cells as a Potential Model of Skin Sarcoid-like Neoplasia. | Int J Mol Sci | 2022 | 35216085 | PubTator, text mining | PubMed |
| Recent Developments in Hyaluronic Acid-Based Hydrogels for Cartilage Tissue Engineering Applications. | Polymers (Basel) | 2022 | 35215752 | PubTator, text mining | PubMed |
| Layer-by-Layer Cell Encapsulation for Drug Delivery: The History, Technique Basis, and Applications. | Pharmaceutics | 2022 | 35214030 | PubTator, text mining | PubMed |
| Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis. | Genes (Basel) | 2022 | 35205284 | PubTator, text mining | PubMed |
| Oncometabolites-A Link between Cancer Cells and Tumor Microenvironment. | Biology (Basel) | 2022 | 35205136 | PubTator, text mining | PubMed |
| Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses. | Diagnostics (Basel) | 2022 | 35204562 | PubTator, text mining | PubMed |
| Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells. | Noncoding RNA | 2022 | 35202088 | PubTator, text mining | PubMed |
| Early prediction of renal graft function: Analysis of a multi-center, multi-level data set. | Curr Res Transl Med | 2022 | 35193070 | PubTator, text mining | PubMed |
| Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. | Nat Med | 2022 | 35190725 | PubTator, text mining | PubMed |
| An in vitro strategy using multiple human induced pluripotent stem cell-derived models to assess the toxicity of chemicals: A case study on paraquat. | Toxicol In Vitro | 2022 | 35182771 | PubTator, text mining | PubMed |
| Identification of functional pathways for regenerative bioactivity of selected renal cells. | Stem Cell Res Ther | 2022 | 35177125 | PubTator, text mining | PubMed |
| Histone H2B Deacylation Selectivity: Exploring Chromatin's Dark Matter with an Engineered Sortase. | J Am Chem Soc | 2022 | 35175758 | PubTator, text mining | PubMed |
| Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells. | Sci Adv | 2022 | 35171685 | PubTator, text mining | PubMed |
| CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. | Mol Syst Biol | 2022 | 35156780 | PubTator, text mining | PubMed |
| RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. | Physiol Rep | 2022 | 35133080 | PubTator, text mining | PubMed |
| Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis. | Biomed Res Int | 2022 | 35132379 | PubTator, text mining | PubMed |
| Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises). | World J Gastrointest Pathophysiol | 2022 | 35116176 | PubTator, text mining | PubMed |
| A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. | Hum Genomics | 2022 | 35109912 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=30